Tel: +44(0)117 928 7321
Epidemiology
You have full text access to this OnlineOpen article
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: Findings from a large, population-based, case–control study (the ProtecT study)
Article first published online: 20 MAY 2010
DOI: 10.1002/ijc.25465
Copyright © 2010 UICC
Additional Information
How to Cite
Murad, A. S., Down, L., Davey Smith, G., Donovan, J. L., Athene Lane, J., Hamdy, F. C., Neal, D. E. and Martin, R. M. (2011), Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: Findings from a large, population-based, case–control study (the ProtecT study). Int. J. Cancer, 128: 1442–1448. doi: 10.1002/ijc.25465
Publication History
- Issue published online: 20 MAY 2010
- Article first published online: 20 MAY 2010
- Accepted manuscript online: 20 MAY 2010 12:00AM EST
- Manuscript Accepted: 29 APR 2010
- Manuscript Received: 17 FEB 2010
Funded by
- UK National Institute for Health Research Health Technology Assessment Programme. Grant Numbers: 96/20/06, 96/20/99
- ProMPT (Prostate Mechanisms of Progression and Treatment)
- NIHR Comprehensive Biomedical Research Centre Grant
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Aspirin and urologic cancer risk: an update, Nature Reviews Urology, 2012, 9, 2, 102
- 2, Prostate-specific antigen kallikrein and non-ST elevation myocardial infarction, International Journal of Cardiology, 2011, 149, 3, 392
- 3, , Prostate-specific antigen levels in hypertensive patients suffering from a non-ST elevation myocardial infarction or a new-onset atrial fibrillation, International Journal of Cardiology, 2011,

1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
